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Introduction
Antinuclear antibodies (ANA) are frequently found in
children with connective tissue diseases but can be also
found in healthy individuals even in absence of autoim-
mune conditions, with a prevalence ranging from 13.3%
(titer ≥1:80) to 5.0% (titer ≥1:160). Puberty is a period of
important changing in immune system because of the
sexual and adenohypophyseal hormones modulation; in
fact many autoimmune and connective tissue diseases
have their onset in this period. To date, a few studies
have evaluated the role of ANA in healthy subjects but
no one has explored their meaning and frequency across
the puberty switch.
Objectives
To evaluate prevalence and persistence of ANA in sub-
jects without any evident autoimmune disease followed
for 3 years, and their possible relationship with chronic
non-inflammatory musculoskeletal pain (MSP).
Methods
Each subject underwent a general and rheumatologic
examination focusing on presence of chronic non-
inflammatory MSP and including the evaluation of the
pubertal stage. Chronic MSP was defined as continuous
or recurrent pain lasting more than 3 months and heav-
ily interfering with daily activities, according to the
International Association for the Study of Pain. Subjects
with past of present sign of any neurological, skeletal,
metabolic or autoimmune conditions were excluded.
Family history for autoimmune diseases in first degree
relatives was also investigated. Finally, each subject
underwent laboratory tests to determine the presence of
ANA, ENA and anti-dsdna, following the international
guidelines. Subjects with ANA positivity (titer ≥1:80)
and/or MSP have been re-evaluated with the same
methods 3 years later.
Results
261 subjects, aged 8-13 years, entered the study. 32
(12.3%) resulted ANA+, equally distributed as far as
gender and pubertal status. None of the ANA+ subjects
resulted positive at ENA or anti-dsdna testing. A posi-
tive family history for autoimmune conditions was
reported in 6.5% of the subjects.
Three years later, in the group of patients followed for
MSP (no. 67) ANA-positivity significantly increased
from 13.4% to 44.8% (p < 0.001) showing a trend to
involve more pre-pubertal subjects than pubertal ones
and more females than males, without statistical signifi-
cance. Particularly, ANA positivity involved more puber-
tal females than pubertal males (50.0% vs 28.0). In the
cohort followed for ANA-positivity (no. 28) 92.9% of
subjects confirmed the ANA-positivity 3 years later,
showing a significant increase of autoantibodies titer
during time (p = 0.002). The prevalence of positive
family history did not significantly changed during the
study period. None of the ANA+ subjects resulted posi-
tive at ENA or anti-dsdna testing. Overall, no significant
association between ANA-positivity and MSP was
found.
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Conclusion
Prevalence and titer of ANA increase across puberty,
especially in females, but have no relationship with
MSP. This phenomenon could be explained by the com-
plex hormonal changing of the puberty switch period.
Further long-term prospective studies are needed to
clarify the potential role of ANA as marker of autoim-
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